Burn Care 3.0: Tissue-Engineered Skin is Regenerative Medicine in Action
According to David H. Ahrenholz, MD, in the December 2015 issue of PSP, the next standard of care for severe burns could be growing patients' own skin.
Tag: US Food and Drug Administration
All
PopularAll
Latest
ASDSA Applauds FDA for Safety Communication on Needle-less Injector Devices
The American Society for Dermatologic Surgery Association supports the U.S. Food and Drug Administration's safety communication regarding needle-less devices, such as hyaluron pens (HA pens) for injection of dermal fillers.
All
Latest
Doctors Encourage COVID Vaccination Despite Reports of Cosmetic Facial Filler Swelling
Experts caution that the side effects from cosmetic fillers are so rare and so mild that they should not dissuade people from getting the COVID-19 vaccine, ABC News reports.
Sientra Reports the Long-Term Safety and Effectiveness of Silicone Gel Breast Implants with Results from the Largest Core Breast Implant Trial To-Date
Plastic and Reconstructive Surgery’s recently published annual supplement included data validating Sientra’s growing portfolio of implants and expanders as safe and innovative options for surgeons and patients undergoing aesthetic or reconstructive breast surgery.
Read MoreExpanding on Breast Tissue Expansion Options: Update on the AeroForm Tissue Expander System
Khashayar Mohebali, MD, shares new information on the AeroForm Tissue Expander System, including clinical trial results, in the October 2015 issue of PSP.
Read MoreFDA Clears Yolo’s Lipofina for Marketing
The FDA granted marketing clearance for LIPOFINA, YOLO’s newest body contouring laser system.
Read MorePower of Two: How Drs Scot Glasberg and Robert X. Murphy, Jr, are Recharging the ASPS
In the April 2015 issue of PSP, Drs Scot Glasberg and Robert X. Murphy, Jr, talk about the changes they’ve made at the ASPS during their presidencies.
Read MoreThe Edge: Three far-reaching Internet marketing myths
In April’s Edge, David Evans, PhD, MBA, debunks Internet marketing myths with reality checks.
Read MoreTake That, Double Chins: FDA Panel Unanimously Backs Kythera’s ATX-101
An FDA advisory panel voted unanimously to approve Kythera’s ATX-101 for the reduction of moderate-to-severe submental fat in adults.
Read MoreBridge Builder: William Ju, MD, Helps Build Bridges Between Dermatologists, Industry, and Venture Capitalists
Through Advancing Innovation in Dermatology, William Ju, MD, is bringing together investors, venture capitalists, doctors, and scientists to spur the development of new treatments for dermatologic problems.
Read More
Hot Stuff: January 2015
Get the scoop on scar-reducing skin care, beauty oil, IDEAL breast implants, and postsurgery bras in PSP’s January 2015 Hot Stuff.
Read More